These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3754980)

  • 1. Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.
    Myerowitz R; Hogikyan ND
    Science; 1986 Jun; 232(4758):1646-8. PubMed ID: 3754980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.
    Myerowitz R
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3955-9. PubMed ID: 3375249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
    Navon R; Proia RL
    Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
    Myerowitz R; Costigan FC
    J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.
    Triggs-Raine B; Richard M; Wasel N; Prence EM; Natowicz MR
    Am J Hum Genet; 1995 Apr; 56(4):870-9. PubMed ID: 7717398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.
    Shore S; Tomczak J; Grebner EE; Myerowitz R
    Hum Mutat; 1992; 1(6):486-90. PubMed ID: 1301958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of three alpha-chain beta-hexosaminidase A mutations among Tay-Sachs carriers.
    Grebner EE; Tomczak J
    Am J Hum Genet; 1991 Mar; 48(3):604-7. PubMed ID: 1825595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gel electrophoretic assay for detecting the insertion defect in Ashkenazi Jewish carriers of Tay-Sachs disease.
    Shore S; Myerowitz R
    Anal Biochem; 1990 Apr; 186(1):179-81. PubMed ID: 2356966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
    Navon R; Proia RL
    Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pedigree discriminant analysis of two French Canadian Tay-Sachs families.
    Keats BJ; Elston RC; Andermann E
    Genet Epidemiol; 1987; 4(2):77-85. PubMed ID: 2953646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation.
    Paw BH; Neufeld EF
    J Biol Chem; 1988 Feb; 263(6):3012-5. PubMed ID: 2449434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin.
    Karpati M; Peleg L; Gazit E; Akstein E; Goldman B
    Clin Genet; 2000 May; 57(5):398-400. PubMed ID: 10852376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.
    Hechtman P; Kaplan F; Bayleran J; Boulay B; Andermann E; de Braekeleer M; Melançon S; Lambert M; Potier M; Gagné R
    Am J Hum Genet; 1990 Nov; 47(5):815-22. PubMed ID: 2220821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.
    Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F
    Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tay-Sachs disease].
    Tanaka A
    Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.